Biocon elevates M B Chinappa as CFO of biosimilar subsidiary
Posted by
www.biotecnika.org
M B Chinappa, who is going to play an important role in Biocon
Biologics' journey towards becoming a global leader in biologics, has
been tasked to drive financial performance of the company and improve
profitability and manage anticipated risks in the journey of achieving
the $1 billion revenue target in FY22, said the company in a press
release.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/biocon-elevates-m-b-chinappa-as-cfo-of-biosimilar-subsidiary/articleshow/73126198.cms
Subscribe to:
Post Comments (Atom)
Post a Comment